Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AHB-137 Followed by TVAX-008 in Chronic Hepatitis B
NCT07876856Phase 2Not yet recruiting
- Sponsor
- AusperBio
- Start
- Oct 2026
- Primary completion
- Sep 2028
01
Overview
A Phase 2 trial of AHB-137, TVAX-008 in Chronic Hepatitis B (CHB), sponsored by AusperBio. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
AHB-137TVAX-008
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07876856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07876856.